Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)

NCT00755456 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

End Stage Renal Disease
Insulin Resistance

Interventions

DRUG: PD solution containing glucose
DRUG: PD solution containing glucose and L-carnitine

Sponsor

Iperboreal Pharma Srl